menu search

QGEN / Qiagen N.V. (QGEN) Q4 2022 Earnings Call Transcript

Qiagen N.V. (QGEN) Q4 2022 Earnings Call Transcript
Qiagen N.V. (NYSE:QGEN ) Q4 2022 Earnings Conference Call February 8, 2023 9:00 AM ET Company Participants John Gilardi - Vice President, Head of Corporate Communications & Investor Relations Thierry Bernard - Chief Executive Officer Roland Sackers - Chief Financial Officer Conference Call Participants Patrick Donnelly - Citi Aisyah Noor - Morgan Stanley Odysseas Manesiotis - Berenberg Derik De Bruin - Bank of America Matt Sykes - Goldman Sachs Andrew Brackmann - William Blair Falko Friedrichs - Deutsche Bank John Sourbeer - UBS Casey Woodring - JPMorgan Hugo Solvet - BNP Ed Ridley-Day - Redburn Operator Ladies and gentlemen, thank you for standing by. Read More
Posted: Feb 8 2023, 14:00
Author Name: Seeking Alpha
Views: 102374

QGEN News  

QIAGEN (QGEN) Q3 Earnings and Revenues Beat, Margins Down

By Zacks Investment Research
October 31, 2023

QIAGEN (QGEN) Q3 Earnings and Revenues Beat, Margins Down

In an increasingly challenging macro environment, QIAGEN (QGEN) surpasses the earnings and revenue outlook in the third quarter of 2023. more_horizontal

Qiagen (QGEN) Reports Q3 Earnings: What Key Metrics Have to Say

By Zacks Investment Research
October 30, 2023

Qiagen (QGEN) Reports Q3 Earnings: What Key Metrics Have to Say

Although the revenue and EPS for Qiagen (QGEN) give a sense of how its business performed in the quarter ended September 2023, it might be worth consi more_horizontal

Qiagen (QGEN) Q3 Earnings and Revenues Surpass Estimates

By Zacks Investment Research
October 30, 2023

Qiagen (QGEN) Q3 Earnings and Revenues Surpass Estimates

Qiagen (QGEN) came out with quarterly earnings of $0.50 per share, beating the Zacks Consensus Estimate of $0.49 per share. This compares to earnings more_horizontal

Here's Why You Should Retain QIAGEN (QGEN) Stock for Now

By Zacks Investment Research
October 18, 2023

Here's Why You Should Retain QIAGEN (QGEN) Stock for Now

Investors are optimistic about QIAGEN's (QGEN) growth in the molecular diagnostics business and the latest acquisition. more_horizontal

QIAGEN (QGEN) Extends QIAwave Product Line With New Kit

By Zacks Investment Research
September 26, 2023

QIAGEN (QGEN) Extends QIAwave Product Line With New Kit

QIAGEN's (QGEN) new QIAwave kits broaden its selection of environmentally friendly products and reaffirm its commitment to helping researchers advance more_horizontal

Qiagen NV (QGEN) Q2 2023 Earnings Call Transcript

By Seeking Alpha
August 9, 2023

Qiagen NV (QGEN) Q2 2023 Earnings Call Transcript

Qiagen NV (NYSE:QGEN ) Q2 2023 Earnings Conference Call August 9, 2023 9:00 AM ET Company Participants John Gilardi - VP, Corporate Communications & I more_horizontal

QIAGEN (QGEN) Q2 Earnings and Revenues Top, '23 View Slashed

By Zacks Investment Research
August 9, 2023

QIAGEN (QGEN) Q2 Earnings and Revenues Top, '23 View Slashed

QIAGEN (QGEN) surpasses the earnings and revenue outlook in the second quarter of 2023 amid a challenging macro environment. more_horizontal

Qiagen (QGEN) Surpasses Q2 Earnings and Revenue Estimates

By Zacks Investment Research
August 8, 2023

Qiagen (QGEN) Surpasses Q2 Earnings and Revenue Estimates

Qiagen (QGEN) came out with quarterly earnings of $0.51 per share, beating the Zacks Consensus Estimate of $0.50 per share. This compares to earnings more_horizontal


Search within

Pages Search Results: